McDonnell Boehnen Hulbert & Berghoff LLP partner Andrew W. Williams, Ph.D. authored an article entitled, “Reports of the death of the patent dance have been slightly exaggerated” that appears in the July 25, 2017 online edition of The Pharma Letter. In a quarterly Special Report piece, Andrew Williams, patent law expert, partner at Chicago-based IP law firm McDonnell Boehnen Hulbert & Berghoff and chairman of its Patent Trial and Appeal Board (PTAB) Trials Practice Group, writes about a crucial case affecting the marketing of biosimilars in the USA. View the article
